Eloxx Pharmaceuticals, Inc. (ELOX)

NCM – Real Time Price. Currency in USD

13.52

+0.88 (6.96%)

At close: Jun 12, 2026, 4:00 PM EDT

14.26

+0.74 (5.47%)

Pre-market: Jun 15, 2026, 7:30 AM EDT

09.06.2026

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

ARLINGTON, Mass., June 8, 2026 /PRNewswire/ -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) ("Eloxx" and the "Company"), a clinical-stage biopharmaceutical company developing novel, small molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations to enable the production of full-length proteins, today announced the pricing of a public offering of 2,975,000 shares of common stock at a public offering price of $11.00 per share and, in lieu of shares of common stock, pre-funded warrants to purchase up to 3,025,000 shares of common stock at a public offering price of $10.99 per pre-funded warrant, which equals the public offering price per share of the common stock less the $0.01 per share exercise price of each pre-funded warrant.

Videos

No Data

There is no data to display

Press releases

09.06.2026

Eloxx Pharmaceuticals, Inc. (ELOX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Videos

No Data

Press releases

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Videos

No Data

Press releases

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Search stocks

Eloxx Pharmaceuticals, Inc. (ELOX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Videos

No Data

Press releases

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq

Videos

No Data

Press releases

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq